About this trial
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.
Eligibility criteria
Qualifiers
Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac;
Patient provides written, informed consent;
Patient is 18 years old or older.
Disqualifiers
MRI exclusion criteria, including
MRI contraindications as per usual clinical care, such as (possible) pregnancy; claustrophobia and metal or electronic implants not compatible with MRI.
Trial design
Treatments tested in this trial
- Radiation therapy
Treatment groups
13
Treatment groupsSee each treatment group below.
Sponsors and collaborators
UMC Utrecht
Lead sponsor
The Netherlands Cancer Institute
Collaborator
Sunnybrook Health Sciences Centre
Collaborator
M.D. Anderson Cancer Center
Collaborator
The Christie NHS Foundation Trust
Collaborator
Royal Marsden NHS Foundation Trust
Collaborator
Medical College of Wisconsin
Collaborator
Elekta Limited
Collaborator
Odense University Hospital
Collaborator
Radboud University Medical Center
Collaborator
Radiotherapiegroep
Collaborator
Jules Bordet Institute
Collaborator
University Hospital Tuebingen
Collaborator
Radiotherapeutic Institute Friesland
Collaborator
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Collaborator
IRCCS Sacro Cuore Don Calabria di Negrar
Collaborator
Austin Health
Collaborator
Princess Margaret Hospital, Canada
Collaborator
Università degli Studi di Brescia
Collaborator